LSPRW (Larkspur Health Acquisition) Debt-to-EBITDA : 0.00 (As of Sep. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSPRW Larkspur Health Acquisition Corp LSPRW
20 GF Score
Price $0.18
! 1 Warning Sign
View Full Analysis

What is Larkspur Health Acquisition Debt-to-EBITDA?

Larkspur Health Acquisition LSPRW 20 Debt-to-EBITDA is 0.00 as of Sep. 2022. GuruFocus rates LSPRW with a GF Score™ of 20/100. The stock has 1 warning sign investors should review.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Larkspur Health Acquisition's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.00 Mil. Larkspur Health Acquisition's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.00 Mil. Larkspur Health Acquisition's annualized EBITDA for the quarter that ended in Sep. 2022 was $-3.94 Mil. Larkspur Health Acquisition's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Larkspur Health Acquisition's Debt-to-EBITDA or its related term are showing as below:

LSPRW's Debt-to-EBITDA is not ranked *
in the Diversified Financial Services industry.
Industry Median: 5.755
* Ranked among companies with meaningful Debt-to-EBITDA only.

Larkspur Health Acquisition  (NAS:LSPRW) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Larkspur Health Acquisition Debt-to-EBITDA Related Terms

Larkspur Health Acquisition Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Larkspur Health Acquisition's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Larkspur Health Acquisition Debt-to-EBITDA Chart

Larkspur Health Acquisition Annual Data
Trend Dec21
Debt-to-EBITDA
N/A

Larkspur Health Acquisition Quarterly Data
Apr21 Sep21 Dec21 Mar22 Jun22 Sep22
Debt-to-EBITDA Get a 7-Day Free Trial N/A 0.00 0.00 0.00 0.00

LSPRW vs CLAY, WTMA, KACL: Debt-to-EBITDA Comparison

For the Shell Companies subindustry, Larkspur Health Acquisition's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Larkspur Health Acquisition Debt-to-EBITDA vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Larkspur Health Acquisition's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Larkspur Health Acquisition's Debt-to-EBITDA falls into.


LSPRW
20GF Score
Larkspur Health Acquisition Corp LSPRW
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Larkspur Health Acquisition Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Larkspur Health Acquisition's Debt-to-EBITDA for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / N/A
=N/A

Larkspur Health Acquisition's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / -3.944
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2022) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of 0.00 mean?
Larkspur Health Acquisition (LSPRW) has a Debt-to-EBITDA of 0.00 as of Sep. 2022. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Larkspur Health Acquisition.
Is Larkspur Health Acquisition's Debt-to-EBITDA too high?
Larkspur Health Acquisition's current Debt-to-EBITDA is 0.00. Overall, Larkspur Health Acquisition has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Larkspur Health Acquisition's Debt-to-EBITDA compare to CLAY and WTMA?
Larkspur Health Acquisition's Debt-to-EBITDA of 0.00 can be compared against companies in the Diversified Financial Services industry. The industry median Debt-to-EBITDA is 5.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Diversified Financial Services company?
The median Debt-to-EBITDA among Diversified Financial Services companies is 5.76, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Larkspur Health Acquisition. For the Diversified Financial Services industry, the median Debt-to-EBITDA is 5.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Larkspur Health Acquisition's current Debt-to-EBITDA is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Larkspur Health Acquisition stock overvalued right now?
Larkspur Health Acquisition (LSPRW) has a current Debt-to-EBITDA of 0.00. The current Debt-to-EBITDA is 0.00. Larkspur Health Acquisition's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Larkspur Health Acquisition (LSPRW), the current Debt-to-EBITDA is 0.00 as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Larkspur Health Acquisition Business Description

Address 100 Somerset Corporate Boulevard, 2nd Floor, Bridgewater, NJ, USA
Larkspur Health Acquisition Corp is a blank check company.
20GF Score

Get the complete analysis for LSPRW

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.18
Price